spot on mate, on balance bob is failing this business, he:- cant...

spot on mate, on balance bob is failing this business, he:
- cant meet timelines
- mis times capital raisings
- seemingly has zero understanding of patient mindsets
- has poor communication and market engagement

this technology has a massive tailwind:
- fda breakthrough status
- conducive regulatory environment in Australia
- supportive government with tax incentives
- major players collaborating in anticipation of the trials
- decades of research

everyone is rooting for Ibx: investors, patients and medical practitioners. Imagine if he was trying to bring a contentious product to market??

if Ibx succeeds it will be despite his involvement.

I’m sure if he wasn’t chairman, the board would be hauling him over the coals as an ineffectual ceo. he’s proving to be neither a strategist nor a communicator.

here we are over 2 weeks since the bombshell and the only information anyone is obtaining is through the cfo. A proper leader would have been a lot more forthcoming with an interview / announcement regarding lessons learnt and a more detailed pathway forward that will give the market confidence.

this sell-off is a loss of faith in management, not the technology.

ibx will get there, but I can’t help but see bob as it’s biggest obstacle.

are you listening bob????? get out there and give the market a reason to have confidence in you.